Expression, Mutation, and Amplification Status of EGFR and Its Correlation with Five miRNAs in Salivary Gland Tumours

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Malignant salivary gland tumors are rare, heterogeneous, and lack defined prognostic factors or therapeutic targets.
• MicroRNAs (miRNAs) roles in salivary gland tumors are understudied.
• Epidermal growth factor receptor (EGFR) is a potential therapeutic target with variable expression in these tumors.

Purpose of the Study:

• To investigate the expression and potential roles of specific miRNAs and EGFR in different parotid gland tumor subtypes.
• To explore the relationship between miRNA expression, EGFR alterations (mutations, CNVs), and tumor behavior.
• To identify potential prognostic factors for salivary gland tumors.

Main Methods:

• Analysis of 70 parotid gland tumors using immunohistochemistry, single-stranded conformation polymorphism, qPCR, and fluorescence in situ hybridization.
• Quantification of EGFR expression, mutations, and copy number variations (CNVs).
• Analysis of five specific miRNAs (miR-99b, miR-133b, miR-140, miR-140-3p, let-7a) expression using qPCR.

Main Results:

• EGFR expression was detected in 37% of low and 40% of high malignant potential tumors.
• No EGFR mutations were found; most samples exhibited chromosome 7 polysomy.
• Differential expression of all five miRNAs was observed across histological subtypes, with associations between miRNA expression, EGFR CNV, and EGFR reactivity.

Conclusions:

• MiRNA expression patterns and EGFR alterations are linked in salivary gland tumors.
• EGFR reactivity is positively associated with miR-133b and let-7a expression.
• Patient age and the need for postoperative radiotherapy are significant prognostic indicators.